Research and Discovery Grand Rounds
The Research & Discovery Grand Rounds series is a monthly presentation highlighting information, resources and advancements in clinical and translational research.
Sessions are typically presented via Zoom on the fourth Thursday of each month from 12:00-1:00PM CT, unless otherwise noted. Reigstration is required. Visit the registration form to sign up for an upcoming session or the entire series.
June 23, 2022, 12:00-1:00- A Unique Entrepreneurial Approach to Bridging the Valley of Death
In this session, Scott Weir, Pharm.D., Ph.D., Director of the Institute for Advancing Medical Innovation, Profesor in the Department of Pharamcology and Therapeutics, Associate Director for Translational Research and Kelly Family Foundation IAMI Professor in Cancer Drug Discovery & Development and Doug Wright, Ph.D., Professor and Vice Chair of Anatomy & Cell Biology, Director of the Kansas IDeA Network of Biomedical Research Excellence, co-PI n the SHARPHub Accelerator Hub to stimulate innovation and commercialization in the Central Regaion IDeA states, and President of the National Association of IDeA Principal Investigators will discuss entrepreneurship strategies in translational research.
July 28, 2022- 12:00-1:00
This session will feature members of the Kansas City Quality and Value Innovation Consortium.
August 25, 2022- 12:00-1:00
This session's topic will be announced soon.
September 22, 2022- 12:00-1:00
This session will focus on diversity and inclusion.
October 27, 2022- 12:00-1:00
In this session, learn about regulatory and knowledge support.
November 17, 2022- 12:00-1:00
This session will explore network capacity.
December 15, 2022- 12:00-1:00
This session will focus on genomics.
View recordings of past Research & Discovery Grand Rounds session.
Taking Advantage of the Frontiers Clinical Research Units
In this session, Mario Castro, M.D., MPH, Professor of Pulmonary, Critical Care and Sleep Medicine at KU Medical Center and Director of Frontiers; Mark A. Clements, M.D., Ph.D., Chair of Endocrinology and Medical Director of the Pediatric Clinical Research Unit at Children's Mercy Hospital; Laura Mussulman, MA, MPH, Administrative Director, CTSU Clinical Research - Fairway; Jill Morris, Ph.D., Assistant Professor, Alzheimer's Disease Center, and KUMC investigator; Mark J. Hamblin, M.D., FCCP, Associate Professor, Pulmonary, Critical Care and Sleep Medicine; and, Jennifer Dolan, MSN, RN, CCRC, Senior Manager, Clinical Research Management and Support at Children's Mercy Hospital, presented use-case scenarios that illustrate strategies for leveraging clinical research units for participant and clinical interactions.
Leveraging Informatics in Translational Research
In this session, Jeffrey A. Thompson, Ph.D., Chief Research Informatics Officer for KU Medical Center and Health System; Mark Hoffman, Ph.D., Chief Research Information Officer for Children's Mercy Research Institute and Professor of Pediatrics at KU and UMKC; and Mei Liu, Ph.D., Associate Professor and Interim Director of Medical Informatics, discussed strategies for leveraging informatics in translational research.
Community Engagement & Translational Research
Dr. K. Allen Greiner, NasonFamily Endowed Professor and Vice Chair of the Department of Family Medicine and Community Health Officer for Wyandotte County -Kansas City, Kansas Public Health Department; Cherayla Haynes, Frontiers Community Health Worker and Recruiter; and Mary Ricketts, President and CEO of Turning Point Training and Development discuss community engagement strategies for translational research. Recorded via Zoom on March 24, 2022.
Biostatistics, Epidemiology & Research Design
Vincent Staggs, Ph.D., and Jonathan Mahnken, Ph.D., co-directors of the Frontiers Biostatistics, Epidemiology and Research Design (BERD) core shared resources available through the Frontiers network and strategies for employing them to advance translational science. Recorded via Zoom on February 24, 2022.
Frontiers Clinical & Translational Science Institute Overview and Outlook
Mario Castro, M.D., MPH and Steve Leeder, Pharm.D., co-directors of Frontiers Clinical and Translational Science Insitute presented an overview and outlook of Frontiers resources and activities. Recorded via Zoom on February 3, 2022.
Jun 07, 2022